Adenosine N1-oxide

Adenosine N1-oxide is an oral active anti-inflammatory agent, and can be isolated from royal jelly. Adenosine N1-oxide promotes osteogenic and adipocyte differentiation[1][2].

Product Specifications

CAS Number

[146-92-9]

UNSPSC

12352005

Target

Others

Type

Natural Products

Related Pathways

Others

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/adenosine-n1-oxide.html

Purity

99.50

Solubility

DMSO : 50 mg/mL (ultrasonic; warming; heat to 60°C)

Smiles

OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](N(C=N2)C3=C2C(N)=[N+]([O-])C=N3)O1

Molecular Formula

C10H13N5O5

Molecular Weight

283.24

References & Citations

[1]Kohno K, et al. Anti-inflammatory effects of adenosine N1-oxide. J Inflamm (Lond) . 2015;12 (1) :2. Published 2015 Jan 20. |[2]Ohashi E, et al. Adenosine N1-Oxide Exerts Anti-inflammatory Effects through the PI3K/Akt/GSK-3β Signaling Pathway and Promotes Osteogenic and Adipocyte Differentiation. Biol Pharm Bull. 2019;42 (6) :968-976.